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Abstract The correlation between hydrocephalus and Chiari
type I malformation (CIM) has been debated since Chiari’s
first descriptions of CIM but some studies have shown that
CIM and hydrocephalus (HCP) could cause symptoms/
disease of each other or vice versa. Recent research has found
that treatment focused on hydrocephalus with ventricle en-
largement also provides alleviation of CIM and even of
syringomyelia. However, the lack of consensus among previ-
ous studies left unanswered the question of how endoscopic
third ventriculostomy (ETV) addresses CIM and why it fails.
Ten symptomatic hydrocephalic patients associated with CIM
underwent ETV fromOctober 2002 toMay 2012. The clinical
features and neuroimaging of all patients were reviewed.
Statistical analysis was applied to evaluate the changes in
the tonsillar ectopia and the ventricle dilation after operation.
The mean follow-up period of this series was 92 months
(range 24–163 months). Eight patients (80%) remained shunt
free or experienced symptom relief following ETV. The re-
maining two patients were identified as failures due to the
deterioration of symptoms or subsequent hindbrain decom-
pression. Endoscopic third ventriculostomy provides an effec-
tive treatment for hydrocephalus associated with CIM, which
can relieve HCP and improve the symptoms of CIM in most
patients. The clinical outcomes are related to the major cause
of the tonsillar herniation.
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Introduction
The correlation between hydrocephalus and Chiari type I mal-
formation (CIM) has been debated since Chiari’s first descrip-
tions of CIM. Chiari postulated that the caudal descent of the
cerebellar tonsils, which was later named BChiari type I mal-
formation^, was the result of the supratentorial pressure
exerted by long-standing hydrocephalus. However, the large
majority of CIM cases presented a normal-sized ventricle [1,
2], so Chiari’s postulation could not reasonably explain the
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research has found that treatment focused on hydrocephalus
with ventricle enlargement also provides alleviation of CIM
and even of syringomyelia; thus, there is a consensus among
clinicians that symptomatic hydrocephalus should be ad-
dressed before CIM. The experiences of treating hydrocephal-
ic patients with concurrent CIM proved Chiari’s postulation to
be seemingly valuable. Abundant research over the last few
decades [3–7] has proven endoscopic third ventriculostomy
(ETV) to be an effective alternative to shunting procedures
in the treatment of obstructive hydrocephalus and special re-
search concerning the application of ETV in hydrocephalic
patients with concurrent CIM began in 1996 [8–13].
Unfortunately, the low CIM incidence hinders the improve-
ment of such research; fewer than 60 cases have been reported
worldwide (Table 1). There was not an obvious difference
between the outcomes in adults and children in these studies.
Some of these studies achieved complete alleviation of the
symptoms induced by both hydrocephalus and CIM and even
a reduction of tonsillar herniation and syringomyelia. The lack
of consensus among previous studies left unanswered the
question of how ETV addresses CIM and why it fails. Our
retrospective study complemented previous work with the
aim of identifying the efficacy of ETV through the outcomes,
analysing the morphological variation and the mutual effect
on both hydrocephalus and CIM, trying to interpret how ETV




The study group was composed of ten inpatients consecutive-
ly treated for symptomatic hydrocephalus associated with
CIM by ETV in our single neurosurgical institute from
October 2002 until May 2012. Physical examinations and
magnetic resonance imaging (MRI) (1.5 T) were carried out
before surgery. The diagnosis of CIM was defined as a tonsil-
lar herniation greater than 5 mm below the foramen magnum
on sagittal MRI images. We classified the presented symp-
toms into Bhydrocephalic symptoms^ (for example, signs of
increased intracranial pressure, cranial nerve VI palsy, devel-
opmental delay, gait disturbances, urinary incontinence, or
macrocrania) and Bclassic CIM-related symptoms^ (for exam-
ple, suboccipital headache, ataxia, or disturbances of spinal
cord function). None of the patients underwent the insertion
of cerebrospinal fluid (CSF) diversion devices or any decom-
pression to address the CIM before ETV. The mean age was
28.14 years (range 0.75–55 years) when ETV was performed.
Treatment
All operations were performed by two experienced neurosur-
geons via a rigid 0° endoscope (Karl Storz GmbH & Co.,
Tuttlingen, Germany) with an operating sheath (outer diame-
ter 6.5 mm, working length 13 cm). Being shunt free and
without hindbrain decompression at the last follow-up was
defined as effective.
Neuroimaging studies
The morphology of hydrocephalus and CIM was assessed in
the image workstation, according to Evan’s Index (EI), the
third ventricle transverse diameter (V3d), fourth ventricle sag-
ittal diameter, and the extent of tonsillar herniation. Other
findings were recorded concerning the expansion of the fourth
ventricle, obstruction of CSF flow (by cine MRI), and the
syrinx. Postoperative data were recorded at the last follow-
up. Statistical analysis was performed using Student’s t test
with significance set at p < 0.05.
Results
Preoperative findings
The clinical findings in these cases are summarized in Table 2.
Nine patients complained of the main symptoms of hydro-
cephalus, including frontal headache, macrocrania, develop-
mental delay, urinary incontinence, paroxysmal unconscious-
ness, nausea, and gait disturbance. Classic symptoms related
to CIM or syringomyelia, including suboccipital headache and
numbness of an upper limb, presented in only two patients.
Table 1 Review of the literature
and current series Author Study time No. of patients Success rate Follow-up time (month)
Fukuhara et al. [14] 2000 5 2/5 Range 3–62.8
Decq et al. [15] 2001 5 5/5 Mean 50.39 (range 14.27–109.37)
Hayhurst et al. [16] 2008 16 15/16 Mean 42 (range 6–96)
Massimi et al. [9] 2011 15 15/15 Mean 35 (range 15–86)
Woodworth et al. [17] 2011 10 Not reported Mean 60 (range 24–108)
Salvador et al. [18] 2014 4 3/4 Mean 104.1 (range 18–164)
Current series 2015 10 8/10 Mean 92 (range 24–163)
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Aqueductal stenosis was evident in one patient, expansion of
the fourth ventricle was evident in four patients, stenosis of
Magendie’s foramen was observed in five patients, and occlu-
sion of the cisterna magna was observed in one patient. No
obstruction of the foramen magnum was identified.
Postoperative complications
No surgical mortality or permanent complications occurred. A
small intra-ventricle haematoma in one patient was observed
via postoperative MR imaging after ETV, and the patient was
discharged from the hospital without symptoms after conserva-
tive treatment. None of the patients died until the last follow-up.
Long-term outcome
The mean follow-up period in this series of patients was
92 months (range 24–163 months). Among the ten pa-
tients, six experienced instant improvement of symptoms,
one saw complete resolution of symptoms, and one
maintained stable symptoms without progressive treat-
ment due to economic and family reasons. The remaining
two patients were identified as failures due to the deteri-
oration of symptoms or the need for secondary surgery.
Ultimately, the effective ratio of ETV was 80% (8/10).
Interestingly, one patient with ventriculomegaly but
asymptomatic hydrocephalus only complained of
suboccipital headache, and ETV apparently relieved the
symptoms. In contrast, another patient who only claimed
to have a frontal headache subsequently underwent a
hindbrain decompression procedure 7 years after the
ETV.
Neuroimaging findings
Pre- and postoperative MRI findings are listed in Table 3. The
mean extent of tonsillar herniation were reduced from mean
9.6 to 9.0 mm after surgery but without significant differences
(p = 0.054) (via Student’s t test). The transverse diameter of
the third ventricle exhibited a reduction that was significant
(p = 0.028). CSF flow was visualized on both sides of the
orifice of the third ventriculostomy via cine MRI in all pa-
tients, confirming its patency and function.
Discussion
When the significant clinical signs and neuroimaging findings
of hydrocephalus are confirmed in patients with mild symp-
tomatic or asymptomatic CIM, treatment should be initiated to
address the hydrocephalus responsible for the increased intra-
cranial pressure. This tendency is fairly common among neu-
rosurgeons. ETV, which has already become a valuable alter-
native to shunting in treating hydrocephalus, was therefore
introduced to manage the hydrocephalus associated with
CIM.
Since the first descriptions of the treatment by Nishihara
et al. in 1996 [12], we reviewed the subsequent literature (ex-
cluding case reports) that has reported on the management of
hydrocephalus associated with CIM via ETV [9, 14–18]
(Table 1). The success rate is not consistent and is in the range
of 40–100%; in this study, it was 80%. The studies with large
samples of mixed types of hydrocephalic patients seemed to
result in higher failure rates than studies with small sample
sizes. Fukuhara et al. reported that Chiari type I malformations
was an important factor in failure rates, although without sig-
nificance in a multivariate analysis [14]. In several specialized
Table 2 Clinical characteristics of ten hydrocephalic patients associated with Chiari I malformation
Case Age (years) Sex Presented syndromes Follow-up (months) Outcome
Hydrocephalus CIM and syringomyelia
1 42 Female Frontal headache 72 Hindbrain decompression
2 27 Male Headache, vomiting 157 Improved
3 1.67 Female Macrocrania, developmental delay 111 Improved
4 0.75 Male Macrocrania, urinary incontinence,
paroxysmal unconsciousness
134 Improved
5 40 Female Headache, nausea, gait disturbance Numbness of upper limb 24 Deterioration
6 34 Female Suboccipital headache 52 Improved
7 34 Male Frontal headache 79 Improved
8 6 Male Macrocrania, headache 86 Improved
9 41 Female Paroxysmal frontal headache, nausea 163 Resolved
10 55 Female Frontal headache 42 Stable
Mean 28.14 92.00
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studies, ETV was effective in controlling hydrocephalus, as
nearly all series reported a shunt-free rate of 100%, even
though a subsequent hindbrain decompression may be re-
quired to resolve CIM [16]. Thus, the key factor determining
the outcome of ETV remains to be explored.
Considering the seemingly low incidence of two diseases
presenting simultaneously on admission, we cannot prove that
hydrocephalus would inevitably cause CIM or vice versa.
However, the mutual effect cannot be ignored. In fact, the first
theory of CIM postulated by Chiari stated that CIM was at-
tributed to the supratentorial pressure exerted by hydrocepha-
lus. This effect exerted on CIM by hydrocephalus has been
observed in several cases. In a study of the natural history of
22 paediatric patients with incidentally recognized CIM, the
clinical signs of the malformation developed only in the two
patients with associated mild hydrocephalus after a mean of
5.9 years’ follow-up [19]. The impact from CIM remained
indeterminate. Majority of researchers attribute the exacerba-
tion of hydrocephalus to obstruction of the fourth ventricle
outlet and the impact of a narrow magnum foramen, which
are both derived from the descending tonsillar. A narrowmag-
num foramen influences the CSF association between the cra-
nial cavity and the spinal canal, which is an important condi-
tion to maintain the normal pressure and flow of CSF. Because
the pulsatile blood flow in the vessel causes the pulsatile pres-
sure of CSF, the dissociation of CSF circulation at the
craniocervical junctional zone stops the pressure transmission,
which then decreases the compliance of both the encephalon
and spinal cord [20].
The results of our ETV research show that the procedure
worked effectively in most patients (80%) with hydrocephalus
and CIM, but there was a failure in a minority of the subjects.
First, we must identify which part of the above correlation can
be affected by ETV. ETV bypassed the third and fourth ven-
tricles to release the pressure of the supratentorial cavity,
which meant decreasing the above pressure due to hydroceph-
alus. Similarly, the obstruction of the fourth ventricle
outlet also can be bypassed via ETV. This was observed in
our study. After the resolution of hydrocephalus, there was a
reduction of the tonsillar descent, as described in other reports
[8, 9, 11, 16]. The average of the tonsillar descent reduced
from 9.6 to 9.0 mm after our ETV; Hayhurst et al. [16] report-
ed an average reduction of 15 to 13.3 mm, and Massimi et al.
[9] reported an average reduction of 12.7 to 8.3 mm.
However, the impact of the narrow magnum foramen
would not be alleviated by ETV, except that the reduced ton-
sillar herniation enlarges the cisterna magna, which results in
the recovery of the CSF association. As expected, an over-
crowded posterior fossa was found in nearly all CIM patients
and remained an important aetiological factor. The concept of
Bcephalo-cranial disproportion^, or disproportionate intracra-
nial volume and skull volume, was introduced by Hoffman
and Tucker in 1976 to describe this overcrowding [21].
Naturally, the skull volume cannot be improved by ETV, but
the intracranial volume may be. Nevertheless, Massimi et al.
postulated a subtype of concurrent CIM and hydrocephalus
with Breversible disproportion^ [22]. These patients presented
an expansion of the fourth ventricle with the normal posterior
fossa, which caused the relative enlargement of the cerebel-
lum. However, the disproportion can be reversed after opera-
tion if the fourth ventricle shrinks to normal size. From this
perspective, if ETV addressed the hydrocephalus and shrank
Table 3 Neuroimaging findings of ten hydrocephalic patients associated with CIM
Case no. Extent of tonsillar
herniation (mm)
Extent of hydrocephalus Other findings




Pre-op Post-op Pre-op Post-op Pre-op Post-op Pre-op Post-op
1 10.8 10.6 0.38 0.36 10.3 8.8 11.2 10.5 Normal V4 stenosis of MF, occlusion of the cisterna magna
2 13.7 13.5 0.35 0.35 11.3 9.4 14.6 14.7 Normal V4
3 7.6 7.4 0.58 0.54 9.9 8.9 8.8 9.3 Normal V4
4 7.2 7.1 0.52 0.59 11.2 13.3 8.2 8.1 Normal V4
5 6.5 6.6 0.49 0.50 19.2 19.0 12.4 16.5 Platybasia, expansion of V4, stenosis of MF
6 8.9 8.3 0.42 0.40 15.9 14.1 29.1 24.3 Expansion of V4, stenosis of MF
7 11.1 7.5 0.36 0.39 11.5 12.2 8.8 11.1 Normal V4, stenosis of aqueduct
8 8.3 8.1 0.44 0.42 16.4 13.9 14.3 13.9 Expansion of V4, stenosis of MF
9 9.5 9.0 0.38 0.32 12.2 6.8 22.0 12.8 Normal V4
10 12.2 11.7 0.40 0.40 16.5 13.8 11.8 11.5 Expansion of V4, stenosis of MF, cervical syrinx
Mean 9.6 9.0 0.43 0.43 13.4 12.0 14.1 13.3 Normal V4
p value 0.054 0.675 0.028 0.24
MFMagendie’s foramen
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the fourth ventricle at the same time, the overcrowding of
posterior fossa would be reversed as well.
According to a previous analysis, ETV is effective in the
mitigation of hydrocephalus and part of CIM; more important-
ly, it blocks the vicious cycle. Thus, the decisive factor of the
outcome should be whether ETV can resolve the major cause
of the tonsillar herniation. Nevertheless, it is still difficult to
identify the primary reason, whether it is supratentorial pressure
from hydrocephalus or an overcrowded posterior fossa. Case 5
of our study did not experience the reduction in herniation after
ETV. This means that the cephalo-cranial disproportion caused
by posterior fossa hypoplasia, such as the platybasia of case 5,
dominates the tonsillar herniation. Additionally, ETV is still
limited in its ability to treat different types of hydrocephalus,
such as communicating hydrocephalus and normal pressure
hydrocephalus. Case 1 was the only patient who presented
stenosis of Magendie’s foramen without expansion of the
fourth ventricle. The cine MR of case 1 also presented the
dissociation of CSF circulation due to stenosis of Magendie’s
foramen and occlusion of the cisterna magna a year after ETV.
We speculate that both explanations related to the tonsillar her-
nia were addressed by ETV. The occlusion of the cisterna
magna was the reason for the failure, which prohibited the
predicted recovery of CSF association resulting from ETV.
Seven years later, a subsequent hindbrain decompression oper-
ation on case 1 finally overcame the limitation of ETV and
resolved the overcrowding of the posterior fossa.
In addition, the assessment of Bcephalo-cranial dispropor-
tion^ was not easy to realize without a common and unified
method. It is thus difficult to clarify the extent to which the
overcrowded posterior fossa would dominate the herniation.
Endoscopic third ventriculostomy provides an effective
treatment for hydrocephalus with concurrent CIM. This out-
come requires addressing the major cause of the tonsillar her-
niation and the limitations of ETV in treating hydrocephalus.
The effectiveness of ETV depends on proper criteria for pa-
tient selection.
Compliance with ethical standards
Funding The National Health and Family Planning commission of the
People’s Republic of China provided financial support in the form of
Research Special Fund for Public Welfare Industry of Health
(201402008) funding.
The sponsor had no role in the design or conduct of this research.
Conflict of interest All authors certify that they have no affiliations
with or involvement in any organization or entity with any financial
interest (such as honoraria; educational grants; participation in speakers’
bureaus; membership, employment, consultancies, stock ownership, or
other equity interest; and expert testimony or patent-licensing arrange-
ments) or non-financial interest (such as personal or professional relation-
ships, affiliations, knowledge, or beliefs) in the subject matter or materials
discussed in this manuscript.
Ethical approval All procedures performed in studies involving hu-
man participants were in accordance with the ethical standards of the
institutional and/or national research committee and with the 1964
Helsinki declaration and its later amendments or comparable ethical
standards.
Informed consent Informed consent was obtained from all individual
participants included in the study.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Elster AD, Chen MY (1992) Chiari I malformations: clinical and
radiologic reappraisal. Radiology 183:347–353. doi:10.1148/
radiology.183.2.1561334
2. Park JK, Gleason PL, Madsen JR, Goumnerova LC, Scott RM
(1997) Presentation and management of Chiari I malformation in
children. Pediatr Neurosurg 26:190–196
3. Gangemi M, Maiuri F, Buonamassa S, Colella G, de Divitiis E
(2004) Endoscopic third ventriculostomy in idiopathic normal pres-
sure hydrocephalus. Neurosurgery 55:129–134. doi:10.1227/01.
neu.0000126938.12817.dc
4. Hellwig D, Grotenhuis JA, Tirakotai W, Riegel T, Schulte DM,
Bauer BL, Bertalanffy H (2005) Endoscopic third ventriculostomy
for obstructive hydrocephalus. Neurosurg Rev 28:1–34 . doi:10.
1007/s10143-004-0365-2discussion 35-38
5. Navarro R, Gil-Parra R, ReitmanAJ, Olavarria G, Grant JA, Tomita
T (2006) Endoscopic third ventriculostomy in children: early and
late complications and their avoidance. Child’s nervous system :
ChNS : official journal of the International Society for Pediatric
Neurosurgery 22:506–513. doi:10.1007/s00381-005-0031-1
6. Rangel-Castilla L, Barber S, Zhang YJ (2012) The role of endo-
scopic third ventriculostomy in the treatment of communicating
hydrocephalus. World neurosurgery 77:555–560. doi:10.1016/j.
wneu.2011.06.038
7. Schroeder HW, Oertel J, Gaab MR (2007) Endoscopic treatment of
cerebrospinal fluid pathway obstructions. Neurosurgery 60:
ONS44–ONS51 . doi:10.1227/01.NEU.0000249242.17805.
E3discussion ONS51-42
8. Buxton N, Jaspan T, Punt J (2002) Treatment of Chiari malforma-
tion, syringomyelia and hydrocephalus by neuroendoscopic third
ventriculostomy. Minimally invasive neurosurgery : MIN 45:231–
234. doi:10.1055/s-2002-36195
9. Massimi L, Pravata E, Tamburrini G, Gaudino S, Pettorini B,
Novegno F, Colosimo C Jr, Di Rocco C (2011a) Endoscopic third
ventriculostomy for the management of Chiari I and related hydro-
cephalus: outcome and pathogenetic implications. Neurosurgery
68:950–956. doi:10.1227/NEU.0b013e318208f1f3
10. Metellus P, Dufour H, Levrier O, Grisoli F (2002) Endoscopic third
ventriculostomy for treatment of noncommunicating syringomyelia
associated with a Chiari I malformation and hydrocephalus: case
report and pathophysiological considerations. Neurosurgery 51:
500–503 . doi:10.1227/01.neu.0000020409.33140.3bdiscussion
503-504
11. Mohanty A, Suman R, Shankar SR, Satish S, Praharaj SS (2005)
Endoscopic third ventriculostomy in the management of Chiari I
Neurosurg Rev
malformation and syringomyelia associated with hydrocephalus. Clin
Neurol Neurosurg 108:87–92. doi:10.1016/j.clineuro.2004.11.017
12. Nishihara T, Hara T, Suzuki I, Kirino T, Yamakawa K (1996) Third
ventriculostomy for symptomatic syringomyelia using flexible en-
doscope: case report. Minimally invasive neurosurgery : MIN 39:
130–132. doi:10.1055/s-2008-1052232
13. Suehiro T, Inamura T, Natori Y, Sasaki M, Fukui M (2000)
Successful neuroendoscopic third ventriculostomy for hydroceph-
alus and syringomyelia associated with fourth ventricle outlet ob-
struction. Case report Journal of neurosurgery 93:326–329. doi:10.
3171/jns.2000.93.2.0326
14. Fukuhara T, Vorster SJ, Luciano MG (2000) Risk factors for failure
of endoscopic third ventriculostomy for obstructive hydrocephalus.
Neurosurgery 46:1100–1109 discussion 1109-1111
15. Decq P, Le Guerinel C, Sol JC, Brugieres P, Djindjian M, Nguyen
JP (2001) Chiari I malformation: a rare cause of noncommunicating
hydrocephalus treated by third ventriculostomy. J Neurosurg 95:
783–790. doi:10.3171/jns.2001.95.5.0783
16. Hayhurst C, Osman-Farah J, Das K, Mallucci C (2008) Initial man-
agement of hydrocephalus associated with Chiari malformation
type I-syr ingomyel ia complex via endoscopic th ird
ventriculostomy: an outcome analysis. J Neurosurg 108:1211–
1214. doi:10.3171/JNS/2008/108/6/1211
17. Woodworth GF, See A, Bettegowda C, Batra S, Jallo GI, Rigamonti
D (2012) Predictors of surgery-free outcome in adult endoscopic
third ventriculostomy. World neurosurgery 78:312–317. doi:10.
1016/j.wneu.2011.09.018
18. Salvador SF, Oliveira J, Pereira J, Barros H, Vaz R (2014)
Endoscopic third ventriculostomy in the management of hydroceph-
alus: outcome analysis of 168 consecutive procedures. Clin Neurol
Neurosurg 126:130–136. doi:10.1016/j.clineuro.2014.08.037
19. Novegno F, Caldarelli M,Massa A, Chieffo D,Massimi L, Pettorini
B, Tamburrini G, Di Rocco C (2008) The natural history of the
Chiari type I anomaly. J Neurosurg Pediatr 2:179–187. doi:10.
3171/PED/2008/2/9/179
20. Greitz D (2004) Radiological assessment of hydrocephalus: new
theories and implications for therapy. Neurosurg Rev 27:145–165
. doi:10.1007/s10143-004-0326-9discussion 166-147
21. Hoffman HJ, Tucker WS (1976) Cephalocranial disproportion. A
complication of the treatment of hydrocephalus in children. Childs
Brain 2:167–176
22. Massimi L, Peppucci E, Peraio S, Di Rocco C (2011b) History of
Chiari type I malformation. Neurological sciences : official journal
of the Italian Neurological Society and of the Italian Society of
Clinical Neurophysiology 32(Suppl 3):S263–S265. doi:10.1007/
s10072-011-0700-7
Neurosurg Rev
